NUTRI-ONCOCARE: New integral nutrition care model to prevent and treat malnutrition in cancer patients
<p><strong>Objective:</strong> The maximum expression of malnutrition in cancer patients is cancerous cachexia, always linked to an unfavorable prognosis. Given its evolutionary nature it is recommended to detect and act early in those patients with nutritional risk. The objec...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-05-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/11299.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p><strong>Objective:</strong> The maximum expression of malnutrition in cancer patients is cancerous cachexia, always linked to an unfavorable
prognosis. Given its evolutionary nature it is recommended to detect and act early in those patients with nutritional risk. The objective is to propose an action
algorithm for the nutritional approach of patients with solid tumors.</p><p><strong>Method:</strong> Through the nominal group technique, specialists in
hospital pharmacy, nutrition and oncology who established a prioritization of issues related to nutritional status and its approach in patients with solid tumors
were brought together. Their discussion and analysis allowed us to design a performance algorithm.</p><p><strong>Results:</strong> The algorithm
differentiates two groups of patients according to the location of the tumor and its impact on nutritional status: high-risk tumors (group 1) include cancers of
the head and neck, upper digestive tract and colorectal and low-risk tumors (group 2) include the rest of the neoplasms. Group 1 patients (with the exception
of those with colorectal cancer) are directly assessed nutritionally in the first 3-5 days after their presentation in the Tumor Committee, starting the
nutritional support required at that time. Patients in group 2 and those diagnosed with colorectal cancer are screened (through NUTRISCORE) after their
presentation in the Committee, those with positive risk being referred to nutritional consultation to perform a complete evaluation and propose treatment
options. Patients without nutritional risk are periodically re- evaluated. Follow-up is planned according to cancer therapy, with continuous monitoring in each
treatment cycle or during the perioperative period.</p><p><strong>Conclusions:</strong> From the nominal group technique, agreements were reached to
propose an algorithm of nutritional approach of the cancer patient. The adoption of the proposed algorithm could reduce variability in institutional clinical
practice, promoting a timely and adequate nutritional approach in cancer patients.</p><p> </p> |
|---|---|
| ISSN: | 1130-6343 2171-8695 |